A recently published study used small non-coding RNAs (snRNA) such as RNU6 and RNU5G, or small nucleolar RNA (snoRNA) SNORD48, as endogenous controls to identify a specific miRNA as a therapeutic target for the treatment of Alzheimer’s disease (AD) [38]. Here, RNU6-1 is linked to early-onset autosomal dominant Alzheimer disease.